Target intelligence / Profile preview

Killer cell lectin like receptor A1, pseudogene (KLRA1P)

Target: KLRA1P
Molecular classification: Other (Pseudogene)

Overview

Killer cell lectin like receptor A1, pseudogene (KLRA1P) is classified as a pseudogene in humans and does not code for a functional protein. The Ly49 gene family encodes activating and inhibitory receptors on natural killer (NK) cells in mice, but in humans, the corresponding region consists of pseudogenes such as KLRA1P, which are not expressed as proteins and have no known biological or therapeutic function. KLRA1P is not considered a therapeutic target, and its nomenclature overlap with functional mouse Ly49 receptors can be a source of confusion[1][2][6][7].

Other names: KLRA1KLRAP1killer cell lectin like receptor A1 pseudogeneLy49 (ambiguous; Ly49 in humans is not an active receptor)

Beyond the preview

Go deeper on Killer cell lectin like receptor A1, pseudogene (KLRA1P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Killer cell lectin like receptor A1, pseudogene (KLRA1P).

Explore the full profile